<DOC>
	<DOCNO>NCT01441960</DOCNO>
	<brief_summary>Electroconvulsive therapy ( ECT ) transcutaneous application small electrical stimulus brain produce generalized seizure treatment select psychiatric disorder severe depression . The aim ECT induce therapeutic tonic seizure person lose consciousness convulsion . Patients need general anesthesia neuromuscular blockade treat pain avoid excessive tonic clonic motor contraction might associate compression fracture . Neuromuscular block drug ( NMBD ) , therefore , administer induction general anesthesia induce neuromuscular blockade . Despite importance NMBDs provide optimal condition ECT treatment , optimal NMBD dose achieve acceptable neuromuscular blockade without excessive untoward effect previously identify study prospective randomize fashion . The aim study , therefore , identify optimal NMBD dose two commonly use neuromuscular block agent ( succinylcholine rocuronium ) order optimize muscle strength modulation ECT facilitate ECT minimal side effect .</brief_summary>
	<brief_title>Optimal Dose Succinylcholine Rocuronium Electroconvulsive Therapy ( ECT )</brief_title>
	<detailed_description>Patients , consent participate study , randomly receive either succinylcholine rocuronium utilize Dixon 's technique . For patient safety , first dose either agent define anesthesiologist provide care , subsequent dos incrementally increase decreased 10 % base assessment psychiatrist blind dose , use dichotomous scale ass quality ECT ( acceptable acceptable ) . The investigator switch second compound soon patient receive one neuromuscular block agent dose result 'acceptable muscle relaxation ' , another dose result 'unacceptable ' condition ' . Acceleromyography use monitor neuromuscular transmission . Following induction general anesthesia , TOF-Watch SX calibrate ( mode 1 , 50 mA ) , train-of-four ( TOF ) stimulation ( every 15 second ) initiate maintained recovery T1 100 % baseline . Non-invasive blood pressure , heart rate , peripheral oxygen saturation ( SpO2 ) , time recovery spontaneous breathing measure procedure . In addition investigator measure stimulation parameter use initiate ECT , well duration seizure well entire procedure time .</detailed_description>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>Adult patient ( age 1880 ) schedule ECT treatment MGH Contraindication use neuromuscular block drug ( e.g . allergy , preexist muscular disease , history malignant hyperthermia ) Malnutrition , general weakness Neurological neuromuscular disease , include paralysis Liver disease liver function test 2x great upper normal limit Kidney disease eGFR &lt; 60 Electrolyte abnormality value outside normal range Pregnancy Cardiac disease abnormal EKG Medications affect seizure threshold blood pressure response Unwilling participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Succinylcholine</keyword>
	<keyword>Rocuronium</keyword>
	<keyword>ECT</keyword>
</DOC>